Company Filing History:
Years Active: 2013-2020
Title: Shoshana Levy: Innovator in Monoclonal Antibody Research
Introduction
Shoshana Levy is a prominent inventor based in Stanford, CA (US). She has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. With a total of 2 patents, her work has the potential to impact therapeutic methods for various diseases.
Latest Patents
One of her latest patents is focused on humanized and chimeric monoclonal antibodies to CD81. These antibodies are designed to bind to human CD81, which is crucial in therapeutic methods aimed at reducing or preventing tumor metastasis. Additionally, her patent includes heavy chain and light chain variable region sequences, along with associated complementarity-determining region (CDR) sequences. Another notable patent involves immunogenic protein constructs that utilize bacterial immunity proteins to enhance immune response to specific antigens.
Career Highlights
Shoshana Levy is affiliated with Leland Stanford Junior University, where she conducts her research and development. Her innovative work in monoclonal antibodies has positioned her as a key figure in the field of immunotherapy.
Collaborations
Throughout her career, Shoshana has collaborated with esteemed colleagues such as Ronald Levy and James Robert Swartz. These partnerships have furthered her research and contributed to advancements in the field.
Conclusion
Shoshana Levy's contributions to monoclonal antibody research exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in the field.